SWOT Analysis for Aurobindo Pharma Ltd. - Weakness

Add SWOT widget to your site/app

Benjamin Graham Value Screen

Rising Net Cash Flow and Cash from Operating activity

PEG lower than Industry PEG

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Top Gainers

Promoters increased pledged shares QoQ

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Near 52 Week Low

Weak Momentum: Price below Short, Medium and Long Term Averages

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

RSI indicating price weakness

High promoter stock pledges

Highest increase in pledges by promoters

Near 52 Week Low

Stocks Underperforming their Industry Price Change in the Quarter

Broker price or reco upgrades in last month

Brokers upgraded recommendation or target price in the past three months

Mutual Funds Increased Shareholding in Past Month

Big Deal (Insider and SAST) buys last month greater than 1% of total shares

Street Favorite: High Analyst Rating with at least 20% upside

Broker Upgrades: Stocks where brokers upgraded recommendation or price target in the past one month

MFs increased their shareholding last quarter

Broker price or reco upgrades in last month

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Recent Broker Downgrades in Reco or Target Price

Broker downgrades in price or recommendation in the past one month

US FDA Warning Letter

Red Flag: Companies seeing significant coronavirus impact

Rising Delivery Percentage Compared to Prev Day

Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes

Indian stocks that could be impacted by Brexit (Britain leaving the EU)

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)